Advent Capital Management’s NEVRO CORP. NVRO Stock Holding History

Advent Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,000	Closed	-$78K	–	260
2018 Q4	$78K	Sell	2,000 -2,000	-50%	-$88.9K	﹤0.01%	193
2018 Q3	$228K	Buy	+4,000	New	+$250K	﹤0.01%	218
2018 Q2	–	Sell	-14,000	Closed	-$1.16M	–	323
2018 Q1	$1.21M	Buy	+14,000	New	+$1.13M	0.02%	187

Other funds holding NVRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Advent Capital Management's NVRO Position: Q1 2019 in Review

Advent Capital Management sold out of NEVRO CORP. (NVRO) in Q1 2019, closing a stake of 2,000 shares — an estimated $78K sold.

Advent Capital Management first reported a position in NVRO in Q1 2018 and held it in 3 quarters. The position peaked at $1.21M in Q1 2018. 172 funds tracked by Wall St. Rank hold NVRO as of Q1 2019.

Advent Capital Management reported no remaining NEVRO CORP. position as of Q1 2019 after selling out during the quarter.
Advent Capital Management sold 2,000 NEVRO CORP. shares in Q1 2019, an estimated $78K.
Advent Capital Management first reported a position in NEVRO CORP. in Q1 2018 and held it in 3 quarters.
Advent Capital Management's NEVRO CORP. position peaked at $1.21M in Q1 2018.
172 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2019.

Based on Advent Capital Management's 13F filing for Q1 2019, filed 15 May 2019.